-
1
-
-
0023636552
-
Production of hybridoma growth factor by human monocytes
-
Aarden, L. A., E. R. De Groot, O. L. Schaap, and P. M. Lansdorp. 1987. Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 17:1411-1416.
-
(1987)
Eur. J. Immunol.
, vol.17
, pp. 1411-1416
-
-
Aarden, L.A.1
De Groot, E.R.2
Schaap, O.L.3
Lansdorp, P.M.4
-
2
-
-
0031894547
-
Cytokine modifiers: Pipe dream or reality?
-
Abraham, E. 1998. Cytokine modifiers: pipe dream or reality? Chest 113: 224S-227S.
-
(1998)
Chest
, vol.113
-
-
Abraham, E.1
-
3
-
-
0032495658
-
Doubleblind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
-
Abraham, E., A. Anzueto, G. Gutierrez, S. Tessler, G. San Pedro, R. Wunderink, A. Dal Nogare, S. Nasraway, S. Berman, R. Cooney, H. Levy, R. Baughman, M. Rumbak, R. B. Light, L. Poole, R. Allred, J. Constant, J. Pennington, S. Porter, and the NORASEPT II Study Group. 1998. Doubleblind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. Lancet 351:929-933.
-
(1998)
Lancet
, vol.351
, pp. 929-933
-
-
Abraham, E.1
Anzueto, A.2
Gutierrez, G.3
Tessler, S.4
San Pedro, G.5
Wunderink, R.6
Dal Nogare, A.7
Nasraway, S.8
Berman, S.9
Cooney, R.10
Levy, H.11
Baughman, R.12
Rumbak, M.13
Light, R.B.14
Poole, L.15
Allred, R.16
Constant, J.17
Pennington, J.18
Porter, S.19
-
4
-
-
0030001667
-
Laparotomy for abdominal sepsis in the critically ill
-
Anderson, I. D., K. C. Fearon, and I. S. Grant. 1996. Laparotomy for abdominal sepsis in the critically ill. Br. J. Surg. 83:535-539.
-
(1996)
Br. J. Surg.
, vol.83
, pp. 535-539
-
-
Anderson, I.D.1
Fearon, K.C.2
Grant, I.S.3
-
5
-
-
0025288396
-
Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist
-
Arend, W. P., H. G. Welgus, R. C. Thompson, and S. P. Eisenberg. 1990. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J. Clin. Investig. 85:1694-1697.
-
(1990)
J. Clin. Investig.
, vol.85
, pp. 1694-1697
-
-
Arend, W.P.1
Welgus, H.G.2
Thompson, R.C.3
Eisenberg, S.P.4
-
6
-
-
0032077839
-
Does hepatocellular injury in sepsis involve apoptosis?
-
Ayala, A., T. A. Evans, and I. H. Chaudry. 1998. Does hepatocellular injury in sepsis involve apoptosis? J. Surg. Res. 76:165-173.
-
(1998)
J. Surg. Res.
, vol.76
, pp. 165-173
-
-
Ayala, A.1
Evans, T.A.2
Chaudry, I.H.3
-
7
-
-
0026649080
-
Systemic cytokine response after major surgery
-
Baigne, R. J., P. M. Lamont, D. Kwiatkowski, M. J. Dallman, and P. J. Morris. 1992. Systemic cytokine response after major surgery. Br. J. Surg. 79: 757-760.
-
(1992)
Br. J. Surg.
, vol.79
, pp. 757-760
-
-
Baigne, R.J.1
Lamont, P.M.2
Kwiatkowski, D.3
Dallman, M.J.4
Morris, P.J.5
-
8
-
-
0029060856
-
Intra-abdominal sepsis
-
Bartlett, J. G. 1995. Intra-abdominal sepsis. Med. Clin. N. Am. 79:599-617.
-
(1995)
Med. Clin. N. Am.
, vol.79
, pp. 599-617
-
-
Bartlett, J.G.1
-
9
-
-
0029684301
-
MOF/MODS, SIRS: An update
-
Baue, A. E. 1996. MOF/MODS, SIRS: an update. Shock 6:S1-S5.
-
(1996)
Shock
, vol.6
-
-
Baue, A.E.1
-
10
-
-
0023182532
-
Evaluating trauma care: The TRISS method. Trauma Score and the Injury Severity Score
-
Boyd, C. R., M. A. Toison, and W. S. Copes. 1987. Evaluating trauma care: the TRISS method. Trauma Score and the Injury Severity Score. J. Trauma 27:370-378.
-
(1987)
J. Trauma
, vol.27
, pp. 370-378
-
-
Boyd, C.R.1
Toison, M.A.2
Copes, W.S.3
-
11
-
-
0027731546
-
Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome
-
Casey, L. C., R. A. Balk, and R. C. Bone. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119:771-778.
-
(1993)
Ann. Intern. Med.
, vol.119
, pp. 771-778
-
-
Casey, L.C.1
Balk, R.A.2
Bone, R.C.3
-
12
-
-
0025205127
-
The Major Trauma Outcome Study: Establishing national norms for trauma care
-
Champion, H. R., W. S. Copes, W. J. Sacco, M. M. Lawnick, S. L. Keast, L. W. Bain, Jr., M. E. Flanagan, and C. F. Frey. 1990. The Major Trauma Outcome Study: establishing national norms for trauma care. J. Trauma 30: 1356-1365.
-
(1990)
J. Trauma
, vol.30
, pp. 1356-1365
-
-
Champion, H.R.1
Copes, W.S.2
Sacco, W.J.3
Lawnick, M.M.4
Keast, S.L.5
Bain L.W., Jr.6
Flanagan, M.E.7
Frey, C.F.8
-
13
-
-
0029835023
-
INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis
-
Cohen, J., J. Carlet, and the International Sepsis Trial Study Group. 1996. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. Crit. Care Med. 24:1431-1440.
-
(1996)
Crit. Care Med.
, vol.24
, pp. 1431-1440
-
-
Cohen, J.1
Carlet, J.2
-
14
-
-
0031178122
-
Therapeutic approaches for clinical ischemia and reperfusion injury
-
Cryer, H. G. 1997. Therapeutic approaches for clinical ischemia and reperfusion injury. Shock 8:26-32.
-
(1997)
Shock
, vol.8
, pp. 26-32
-
-
Cryer, H.G.1
-
15
-
-
0029073745
-
Antibiotic treatment of sepsis
-
Cunha, B. A. 1995. Antibiotic treatment of sepsis. Med. Clin. N. Am. 79: 551-558.
-
(1995)
Med. Clin. N. Am.
, vol.79
, pp. 551-558
-
-
Cunha, B.A.1
-
16
-
-
0026575846
-
Cytokine serum level during severe sepsis in human IL-6 as a marker of severity
-
Damas, P., D. Ledoux, M. Nys, Y. Vrindts, D. De Groote, P. Franchimont, and M. Lamy. 1992. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg. 215:356-362.
-
(1992)
Ann. Surg.
, vol.215
, pp. 356-362
-
-
Damas, P.1
Ledoux, D.2
Nys, M.3
Vrindts, Y.4
De Groote, D.5
Franchimont, P.6
Lamy, M.7
-
17
-
-
0033174324
-
Immunopathologic responses to non-lethal sepsis
-
Ebong, S. J., D. R. Call, G. L. Bolgos, D. E. Newcomb, J. I. Granger, M. O'Reilly, and D. G. Remick. 1999. Immunopathologic responses to non-lethal sepsis. Shock 12:118-126.
-
(1999)
Shock
, vol.12
, pp. 118-126
-
-
Ebong, S.J.1
Call, D.R.2
Bolgos, G.L.3
Newcomb, D.E.4
Granger, J.I.5
O'Reilly, M.6
Remick, D.G.7
-
18
-
-
0025258906
-
Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis
-
Echtenacher, B., W. Falk, D. N. Mannel, and P. H. Krammer. 1990. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145:3762-3766.
-
(1990)
J. Immunol.
, vol.145
, pp. 3762-3766
-
-
Echtenacher, B.1
Falk, W.2
Mannel, D.N.3
Krammer, P.H.4
-
19
-
-
0025951812
-
The complex pattern of cytokines in sepsis. Association between prostaglandins, cachectin, and interleukins
-
Ertel, W., M. H. Morrison, P. Wang, Z. F. Ba, A. Ayala, and I. H. Chaudry. 1991. The complex pattern of cytokines in sepsis. Association between prostaglandins, cachectin, and interleukins. Ann. Surg. 214:141-148.
-
(1991)
Ann. Surg.
, vol.214
, pp. 141-148
-
-
Ertel, W.1
Morrison, M.H.2
Wang, P.3
Ba, Z.F.4
Ayala, A.5
Chaudry, I.H.6
-
20
-
-
0026585007
-
Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia
-
Eskandari, M. K., G. Bolgos, C. Miller, D. T. Nguyen, L. E. DeForge, and D. G. Remick. 1992. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immu-nol. 148:2724-2730.
-
(1992)
J. Immunol.
, vol.148
, pp. 2724-2730
-
-
Eskandari, M.K.1
Bolgos, G.2
Miller, C.3
Nguyen, D.T.4
DeForge, L.E.5
Remick, D.G.6
-
21
-
-
0025309598
-
WEHI 164 subclone 13 assay for TNF: Sensitivity, specificity, and reliability
-
Eskandari, M. K., D. T. Nguyen, S. L. Kunkel, and D. G. Remick. 1990. WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability. Immunol. Investig. 19:69-79.
-
(1990)
Immunol. Investig.
, vol.19
, pp. 69-79
-
-
Eskandari, M.K.1
Nguyen, D.T.2
Kunkel, S.L.3
Remick, D.G.4
-
22
-
-
0022972464
-
A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes
-
Espevik, T., and J. Nissen Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99-105.
-
(1986)
J. Immunol. Methods
, vol.95
, pp. 99-105
-
-
Espevik, T.1
Nissen Meyer, J.2
-
23
-
-
0024822480
-
Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models
-
Evans, G. F., Y. M. Snyder, L. D. Butler, and S. H. Zuckerman. 1989. Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models. Circ. Shock 29:279-290.
-
(1989)
Circ. Shock
, vol.29
, pp. 279-290
-
-
Evans, G.F.1
Snyder, Y.M.2
Butler, L.D.3
Zuckerman, S.H.4
-
24
-
-
0031753175
-
Increased serum interleukin-8: Correlation with poor prognosis in patients with postoperative multiple organ failure
-
Hamano, K., H. Gohra, H. Noda, T. Katoh, Y. Fujimura, N. Zempo, and K. Esato. 1998. Increased serum interleukin-8: correlation with poor prognosis in patients with postoperative multiple organ failure. World J. Surg. 22:1077-1081.
-
(1998)
World J. Surg.
, vol.22
, pp. 1077-1081
-
-
Hamano, K.1
Gohra, H.2
Noda, H.3
Katoh, T.4
Fujimura, Y.5
Zempo, N.6
Esato, K.7
-
25
-
-
0030905548
-
Infections and the inflammatory response in acute respiratory distress syndrome
-
Headley, A. S., E. Tolley, and G. U. Meduri. 1997. Infections and the inflammatory response in acute respiratory distress syndrome. Chest 111:1306-1321.
-
(1997)
Chest
, vol.111
, pp. 1306-1321
-
-
Headley, A.S.1
Tolley, E.2
Meduri, G.U.3
-
26
-
-
0028828688
-
Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis
-
Holzheimer, R. G., M. Schein, and D. H. Wittmann. 1995. Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis. Arch. Surg. 130:1314-1320.
-
(1995)
Arch. Surg.
, vol.130
, pp. 1314-1320
-
-
Holzheimer, R.G.1
Schein, M.2
Wittmann, D.H.3
-
27
-
-
0030736624
-
Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis
-
Keel, M., U. Ungethum, U. Steckholzer, E. Niederer, T. Hartung, O. Trentz, and W. Ertel. 1997. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 90:3356-3363.
-
(1997)
Blood
, vol.90
, pp. 3356-3363
-
-
Keel, M.1
Ungethum, U.2
Steckholzer, U.3
Niederer, E.4
Hartung, T.5
Trentz, O.6
Ertel, W.7
-
28
-
-
0029315216
-
The physical nature of a large bowel perforation predicts severity of the subsequent inflammatory response
-
Lundblad, R., P. Sandven, and K. E. Giercksky. 1995. The physical nature of a large bowel perforation predicts severity of the subsequent inflammatory response. Shock 3:455-461.
-
(1995)
Shock
, vol.3
, pp. 455-461
-
-
Lundblad, R.1
Sandven, P.2
Giercksky, K.E.3
-
29
-
-
0028231333
-
Interleukin-10 production during septicaemia
-
Marchant, A., J. Deviere, B. Byl, D. De Groote, J. L. Vincent, and M. Goldman. 1994. Interleukin-10 production during septicaemia. Lancet 343:707-708.
-
(1994)
Lancet
, vol.343
, pp. 707-708
-
-
Marchant, A.1
Deviere, J.2
Byl, B.3
De Groote, D.4
Vincent, J.L.5
Goldman, M.6
-
30
-
-
0032134864
-
Antibiotic treatment influences outcome in murine sepsis: Mediators of increased morbidity
-
Newcomb, D., G. Bolgos, L. Green, and D. G. Remick. 1998. Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity. Shock 10:110-117.
-
(1998)
Shock
, vol.10
, pp. 110-117
-
-
Newcomb, D.1
Bolgos, G.2
Green, L.3
Remick, D.G.4
-
31
-
-
0030877935
-
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial
-
Opal, S. M., C. J. Fisher, Jr., J. F. Dhainaut, J. L. Vincent, R. Brase, S. F. Lowry, J. C. Sadoff, G. J. Slotman, H. Levy, R. A. Balk, M. P. Shelly, J. P. Pribble, J. F. LaBrecque, J. Lookabaugh, H. Donovan, H. Dubin, R. Baughman, J. Norman, E. DeMaria, K. Matzel, E. Abraham, M. Seneff, and the Interleukin-1 Receptor Antagonist Sepsis Investigator Group. 1997. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. Crit. Care Med. 25:1115-1124.
-
(1997)
Crit. Care Med.
, vol.25
, pp. 1115-1124
-
-
Opal, S.M.1
Fisher C.J., Jr.2
Dhainaut, J.F.3
Vincent, J.L.4
Brase, R.5
Lowry, S.F.6
Sadoff, J.C.7
Slotman, G.J.8
Levy, H.9
Balk, R.A.10
Shelly, M.P.11
Pribble, J.P.12
LaBrecque, J.F.13
Lookabaugh, J.14
Donovan, H.15
Dubin, H.16
Baughman, R.17
Norman, J.18
DeMaria, E.19
Matzel, K.20
Abraham, E.21
Seneff, M.22
more..
-
32
-
-
0024405217
-
The cardiovascular pathophysiology of sepsis
-
Parillo, J. E. 1989. The cardiovascular pathophysiology of sepsis. Annu. Rev. Med. 40:469-485.
-
(1989)
Annu. Rev. Med.
, vol.40
, pp. 469-485
-
-
Parillo, J.E.1
-
33
-
-
0029348036
-
Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture
-
Remick, D., P. Manohar, G. Bolgos, J. Rodriguez, L. Moldawer, and G. Wollenberg. 1995. Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 4:89-95.
-
(1995)
Shock
, vol.4
, pp. 89-95
-
-
Remick, D.1
Manohar, P.2
Bolgos, G.3
Rodriguez, J.4
Moldawer, L.5
Wollenberg, G.6
-
34
-
-
0031954179
-
Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis
-
Remick, D. G., S. J. Garg, D. E. Newcomb, G. Wollenberg, T. K. Huie, and G. L. Bolgos. 1998. Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis. Crit. Care Med. 26:895-904.
-
(1998)
Crit. Care Med.
, vol.26
, pp. 895-904
-
-
Remick, D.G.1
Garg, S.J.2
Newcomb, D.E.3
Wollenberg, G.4
Huie, T.K.5
Bolgos, G.L.6
-
35
-
-
0031848913
-
Pulmonary and hepatic gene expression following cecal ligation and puncture: Monophosphoryl lipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration
-
Salkowski, C. A., G. Detore, A. Franks, M. C. Falk, and S. N. Vogel. 1998. Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration. Infect. Immun. 66:3569-3578.
-
(1998)
Infect. Immun.
, vol.66
, pp. 3569-3578
-
-
Salkowski, C.A.1
Detore, G.2
Franks, A.3
Falk, M.C.4
Vogel, S.N.5
-
36
-
-
0023491364
-
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
-
Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664.
-
(1987)
Nature
, vol.330
, pp. 662-664
-
-
Tracey, K.J.1
Fong, Y.2
Hesse, D.G.3
Manogue, K.R.4
Lee, A.T.5
Kuo, G.C.6
Lowry, S.F.7
Cerami, A.8
-
37
-
-
0028970736
-
Endogenous IL-10 protects mice from death during septic peritonitis
-
van der Poll, T., A. Marchant, W. A. Buurman, L. Berman, C. V. Keogh, D. D. Lazarus, L. Nguyen, M. Goldman, L. L. Moldawer, and S. F. Lowry. 1995. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol. 155:5397-5401.
-
(1995)
J. Immunol.
, vol.155
, pp. 5397-5401
-
-
Van Der Poll, T.1
Marchant, A.2
Buurman, W.A.3
Berman, L.4
Keogh, C.V.5
Lazarus, D.D.6
Nguyen, L.7
Goldman, M.8
Moldawer, L.L.9
Lowry, S.F.10
-
38
-
-
0029080432
-
Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin
-
Villa, P., G. Sartor, M. Angelini, M. Sironi, M. Conni, P. Gnocchi, A. M. Isetta, G. Grau, W. Buurman, and L. J. van Tits. 1995. Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin. Diagn. Lab. Immunol. 2:549-553.
-
(1995)
Clin. Diagn. Lab. Immunol.
, vol.2
, pp. 549-553
-
-
Villa, P.1
Sartor, G.2
Angelini, M.3
Sironi, M.4
Conni, M.5
Gnocchi, P.6
Isetta, A.M.7
Grau, G.8
Buurman, W.9
Van Tits, L.J.10
-
39
-
-
0030921892
-
Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality
-
Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Strieter, and S. L. Kunkel. 1997. Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality. Infect. Immun. 65:3847-3851.
-
(1997)
Infect. Immun.
, vol.65
, pp. 3847-3851
-
-
Walley, K.R.1
Lukacs, N.W.2
Standiford, T.J.3
Strieter, R.M.4
Kunkel, S.L.5
-
40
-
-
0026582215
-
Anti-endotoxin monoclonal antibodies - A second look
-
Editorial
-
Wenzel, R. P. 1992. Anti-endotoxin monoclonal antibodies - a second look N. Engl. J. Med. 326:1151-1153. (Editorial.)
-
(1992)
N. Engl. J. Med.
, vol.326
, pp. 1151-1153
-
-
Wenzel, R.P.1
-
41
-
-
0018964280
-
Sepsis and septic shock - A review of laboratory models and a proposal
-
Wichterman, K. A., A. E. Baue, and I. H. Chaudry. 1980. Sepsis and septic shock - a review of laboratory models and a proposal. J. Surg. Res. 29:189-201.
-
(1980)
J. Surg. Res.
, vol.29
, pp. 189-201
-
-
Wichterman, K.A.1
Baue, A.E.2
Chaudry, I.H.3
-
42
-
-
0032127156
-
Changes in immune-endocrine response after surgery
-
Yamauchi, H., E. Kobayashi, T. Yoshida, H. Kiyozaki, Y. Hozumi, R. Kohiyama, Y. Suminaga, I. Sakurabayashi, A. Fujimura, and M. Miyata. 1998. Changes in immune-endocrine response after surgery. Cytokine 10:549-554.
-
(1998)
Cytokine
, vol.10
, pp. 549-554
-
-
Yamauchi, H.1
Kobayashi, E.2
Yoshida, T.3
Kiyozaki, H.4
Hozumi, Y.5
Kohiyama, R.6
Suminaga, Y.7
Sakurabayashi, I.8
Fujimura, A.9
Miyata, M.10
|